Related Experiment Videos
Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by
K Kubota1, H Kurabayashi, J Tamura
1Department of Medicine, Kusatsu Branch Hospital, Gunma University School of Medicine, Japan.
Journal of Medicine
|January 1, 1992
Abstract:
We report on a 74-year-old female patient with primary hemochromatosis complicated by hyperthyroidism. The serum ferritin level was reduced throughout a 217 day administration of deferoxamine (1 g/day). At the same time, the thyroid gland was changed from hyper- to hypo- functional proportionally.